← Back to Search

Behavioural Intervention

Breathe Easier Intervention for Lung Cancer Survivors (BE Trial)

N/A
Recruiting
Led By Karen K McDonnell, PhD
Research Sponsored by University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up daily for 6 months
Awards & highlights

BE Trial Summary

This trial tests a 12-week intervention to reduce symptoms & change behaviors in lung cancer survivors & their family members, w/the goal of improving health outcomes.

Who is the study for?
This trial is for early-stage lung cancer survivors (stages I-III) and a family member or friend, both willing to try a new lifestyle program. They must speak English, be over 21, able to consent, use text messages, and have healthcare provider approval. It's not for those with advanced lung cancer (stage IV), mobility issues due to certain diseases, or who are advised against physical activity.Check my eligibility
What is being tested?
The 'Breathe Easier' intervention in this pilot study aims to reduce symptoms like breathlessness and stress while promoting physical activity and better stress management among lung cancer survivors and their companions. The study involves face-to-face sessions, phone calls over 12 weeks, plus follow-ups at three months.See study design
What are the potential side effects?
Since 'Breathe Easier' focuses on lifestyle changes rather than medication or medical procedures, side effects may include muscle soreness from increased physical activity or emotional discomfort as participants adjust to new stress management techniques.

BE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~daily for 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and daily for 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in perceived stress
Change in the symptom of breathlessness
Change in the symptom of dyspnea
+3 more
Secondary outcome measures
Tobacco use abstinence
Other outcome measures
Affective balance change
Cognition change
Emotional response to dyspnea change
+4 more

BE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: BE Intervention GroupExperimental Treatment1 Intervention
The BE Manual is an educational resource for Managing Stress, Increasing Physical Activity (PA) and Stopping Smoking and Staying Smoke free. A timed, weekly telephone counseling session (60 min./dyad max) will be recorded. The purpose is to provide social support with SMART goal setting, adherence monitoring, encouragement.. Breathing Exercises and Meditations are incorporated into the BE Manual and sent by a link via text messages. A Texting Library provides additional education, support, and encouragement daily. There are 5 story lines: BE Active, BE Kind to Yourself, BE Supportive and BE Smoke free (offered to current smokers only). Stay Smoke free will be instituted once tobacco use has stopped. Weekly Logs for tracking goals and progress with behavior changes (PA, breathing practices and meditations) and a pedometer are provided. After 12 weeks, the calls and texts will be tapered.
Group II: Attention ControlActive Control1 Intervention
Education: Each survivor will receive a copy of "Facing Forward; Life After Cancer Treatment" (No. 18-2424, March 2018). Each family member or friend will receive "When Someone You Love is Being Treated for Cancer" (No. 14-5726, May 2014). Specific parts of booklets will be reviewed during the 15-minute/per participant telephone "chat". Telephone "Chats": The primary purpose is study retention. After the first 12-week period ends the weekly chats will be tapered for 12 weeks. One text message delivered weekly by telephone is a reminder of the day and time of the chat(s). Tobacco Use Reduction: Many survivors of lung cancer struggle with nicotine addiction; smoking cessation and relapse prevention content will be made available to current smokers (The FOREVER FREE program - a free, twelve short booklet evidence-based resource created by the H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida).

Find a Location

Who is running the clinical trial?

Brown UniversityOTHER
456 Previous Clinical Trials
563,021 Total Patients Enrolled
University of South CarolinaLead Sponsor
211 Previous Clinical Trials
120,399 Total Patients Enrolled
Karen K McDonnell, PhDPrincipal InvestigatorUniversity of South Carolina

Media Library

Breathe Easier (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05956782 — N/A
Non-Small Cell Lung Cancer Research Study Groups: BE Intervention Group, Attention Control
Non-Small Cell Lung Cancer Clinical Trial 2023: Breathe Easier Highlights & Side Effects. Trial Name: NCT05956782 — N/A
Breathe Easier (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05956782 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for potential participants to join this trial?

"Affirmative. Data on clinicaltrials.gov makes clear that this trial is still looking for patient participants and was initially posted on June 15th 2022, with the most recent update taking place July 11th 2023. 60 volunteers are sought from one location."

Answered by AI

How many participants have been recruited for this clinical research?

"Affirmative. The clinical trial portal confirms that this medical research, posted on June 15th 2022 and modified recently on July 11th 2023, is still in the process of recruiting their participants; the goal being 60 people from a single location."

Answered by AI
~21 spots leftby Apr 2025